Business Description
Surrozen is a biotechnology company based in South San Francisco, California, focused on developing antibody-based treatments that activate the body's natural tissue repair processes across a wide range of organs, including the eye, liver, lung, and kidney. Its most advanced programs target eye diseases such as diabetic macular edema, age-related macular degeneration, and corneal conditions, with several drug candidates designed to work on multiple biological targets at once. The company also has active partnerships with Boehringer Ingelheim and TCGFB Inc. to expand its research into additional disease areas, including lung scarring. Founded in 2015, Surrozen continues to build a broad pipeline aimed at treating conditions where the body struggles to repair damaged tissue on its own.
